Norpace Cr
Product Images NDC 0025-2732

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Norpace Cr (NDC 0025-2732). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Pfizer Laboratories Div Pfizer Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Norpace 01)

Chemical structure of disopyramide phosphate, the active ingredient in Norpace CR 100 mg and 150 mg tablets by Pfizer Laboratories Div Pfizer Inc. The structure shows a pyridine and benzene ring attached to a substituted amide with phosphate group.*

FDA Label Image

G.d. Searle Llc Logo (Norpace 02)

FDA Label Image

Principle Display Panel (100 mg Bottle Label)

Label for Norpace 100 mg capsules, disopyramide phosphate USP, by Pfizer Laboratories. The label states the product contains 100 capsules, is for prescription use only, and includes storage instructions, manufacturer details, and the NDC 0025-2752-31.*

FDA Label Image

Principle Display Panel (150 mg Bottle Label)

Norpace CR 150 mg capsules label showing disopyramide phosphate as the active ingredient. The label indicates 100 capsules per container, for oral use as capsules. The product is distributed by Pfizer Laboratories, a division of Pfizer Inc. Storage instructions advise controlled room temperature (15-30°C). The label also includes a barcode and notes the product is made in Japan.*

FDA Label Image

Principle Display Panel (100 mg Bottle Label)

Norpace CR 100 mg extended-release capsules label showing disopyramide phosphate as the active ingredient. The label includes storage instructions at 25°C with permitted excursions, dispensing information, and capsule count of 100. It is distributed by Pfizer Laboratories, Division of Pfizer Inc., and indicates the product is made in Japan.*

FDA Label Image

Principle Display Panel (150 mg Bottle Label)

Label for Norpace CR 150 mg extended-release capsules containing disopyramide phosphate. The label shows packaging for 100 capsules by Pfizer Laboratories Division of Pfizer Inc. It includes storage instructions, dosage form, NDC 0025-2742-31, and indicates prescription use only.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.